Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

4)k License and royalty fees 10,431 - 10,431 14,258 - 14,258 Research and devel- opment 23,701 (1,866)c 21,411 53,192 (938)c 47,657 (424)d (795)d - (3,802)b Selling, general and admin- istrative 81,504 (2,659)b 74,393 98,483 (6,983)b 86,524 (1,155)d (1,641)d (3,297)g (2,670)g - (665)f Depreciation and amortiz- ation 33,251 (29,956)e 3,295 33,998 (30,219)e 3,779 In-process research and development - - - 2,500 (2,500)c - Write-down of assets held for sale 3,090 (3,090)i - 1,283 (1,283)i - Write-down of goodwill - - - 649,685 (649,685)i - ------------------------------------------------------------------------- 256,593 (44,712) 211,881 954,451 (701,303) 253,148 ------------------------------------------------------------------------- Operating income (loss) 23,085 19,156 42,241 (671,179) 700,393 29,214 ------------------------------------------------------------------------- Ot
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... BARBARA, CALIFORNIA (PRWEB) March 04, 2015 ... consulting firm in the life sciences industry, hired ... Blewitt leads the Cloud Compliance Services and Solutions ... companies utilize cloud based applications while maintaining compliance with ... years, Blewitt has been an accomplished life sciences regulatory ...
(Date:3/4/2015)... DUBLIN , Mar. 04, 2015 Research ... announced the addition of the "Global Biologics ... their offering. , The Global ... professional and in-depth study on the current state ... The report provides a basic overview of the ...
(Date:3/4/2015)... San Bruno, CA. (PRWEB) March 04, 2015 ... Organization (CRO) headquartered in the San Francisco Bay Area, ... Clinical Trials (OCT) Israel Conference 2015 on March ... PRC Clinical seeks to build relationships with Israeli life ... Administration (FDA) clinical trials. The company’s services span all ...
(Date:3/4/2015)... REDWOOD CITY, Calif. , March 4, 2015 ... ACRX ), a specialty pharmaceutical company focused on ... the treatment of acute and breakthrough pain, today ... yearly 2014 financial results after market close on ... an investment-community conference call at 4:30 p.m. Eastern ...
Breaking Biology Technology:USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3Global Biologics and Biosimilars Industry Report 2015-2020 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3
... N.Y., Jan. 28 XTL Biopharmaceuticals Ltd. (Nasdaq: ... January 27, 2009 it received a Staff Determination Letter ... the Company that the staff of Nasdaq,s Listing Qualifications ... Rule 4300, that the Company,s American Depository Shares ("ADRs") ...
... Binding Site Limited,("The Binding Site" or the "Company"), ... publication of the first,international guidelines recommending first-line use ... myeloma, a cancer of cells in the bone,marrow, ... The guidelines were written on behalf ...
... Business Development , ... Olyphant, PA (PRWEB) January 28, 2009 -- ... the hiring of Mr. Terry Ladd as Vice President of Business Development. ... Director, Business Development and Marketing., , , , ,Mr. Ladd will be ...
Cached Biology Technology:International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 2International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 3International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 4International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 5International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 6International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 7Calvert Labs Announces the Hiring of Terry Ladd 2
(Date:2/5/2015)... 2015 Despite a lack of advancements ... as consumer electronics, automotive, storage and telecommunication has ... (SMT) screen printers. Innovations in electronics and conversion ... the adoption curve up. Meanwhile, sale volumes of ... dispensers are indispensable in the production of complex ...
(Date:1/22/2015)... CHICAGO , Jan. 9, 2015 Valid S.A. ("Company") ... the market in general the State of Washington,s ... contract for a new enrollment and central issuance system for ... The project planning and development will start ...
(Date:1/22/2015)... Fla. , Jan. 13, 2015  Today, FreeWavz ... technology, launched its crowdfunding campaign on Fundable, ... the build of production capacity to meet customer ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... in Munich, Germany and Ann Arbor, Michigan released today ... National Institute on Aging, National Institutes of Health, Baltimore, ... cells. , In their work they first identified and ... methods. Then they employed extensive DNA promoter analysis based ...
... Throughout the world, amateurs, experts and the media agree ... that the bodys own opioids, so called endorphins, are ... never been proved until now. Researchers at the Technische ... demonstrate the existence of an endorphin driven runners high. ...
... ... Entry, WASHINGTON, Feb. ... Department of Homeland Security (DHS) is,expanding the operation of their successful biometrics-at-sea ... securing the more than 95,000 miles of,America,s coastline," said Rear Adm. Wayne ...
Cached Biology News:The myth of runner's high revisited with brain imaging 2The myth of runner's high revisited with brain imaging 3DHS Expands Biometrics-at-Sea Program to the Florida Straits 2
Alkaline Phosphatase Stabilizer Solution, 1 L...
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast...
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
... Our fastest automated perfusion system. ... in perfusion, physiology, biophysics, electrochemistry, or ... reproducibility with 1.5-4 millisecond accuracy ... Microprocessor-based for accuracy and flexibility ...
Biology Products: